Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes.

Ciulla, Thomas; Pollack, John S; Williams, David F

Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes.

Ciulla, Thomas; Pollack, John S; Williams, David F.

Affiliation

Ciulla T; Retina Service, Midwest Eye Institute, Indianapolis, Indiana, USA thomasciulla@gmail.com.
Pollack JS; Indiana University School of Medicine, Indianapolis, Indiana, USA.
Williams DF; Rush University, Chicago, Illinois, USA.

Br J Ophthalmol ; 105(12): 1696-1704, 2021 12.

Article in En | MEDLINE | ID: mdl-33055088

Subject(s)

Macular Edema; Retinal Vein Occlusion; Aged; Angiogenesis Inhibitors/therapeutic use; Bevacizumab/therapeutic use; Endothelial Growth Factors; Female; Humans; Intravitreal Injections; Macular Edema/diagnosis; Macular Edema/drug therapy; Macular Edema/etiology; Ranibizumab/therapeutic use; Retinal Vein Occlusion/complications; Retinal Vein Occlusion/diagnosis; Retinal Vein Occlusion/drug therapy; Retrospective Studies; Vascular Endothelial Growth Factor A; Visual Acuity

Key words

Macula; Retina; Treatment Medical

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Vein Occlusion / Macular Edema Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: Br J Ophthalmol Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google